ACUT

0.11800.00%
WE

Wendy E. Blosser

CEO & Director

Ms. Wendy E. Blosser serves as Chief Executive Officer and Director of Accustem Sciences, Inc since March 2022. She serves as Chief Executive Officer of AccuStem Sciences Limited since March 2022 and serves as its Director since March 30, 2022. From May of 2019 through March 2021, Ms. Blosser served as Chief Commercial Officer at Agendia N.V. From March 2018 to May 2019, Ms. Blosser held multiple executive roles for the Caravel Ventures portfolio (Animated Dynamics, Strand Diagnostics). From February 2015 to March 2018, Ms. Blosser was Vice President of Sales (February 2015 to March 2017) and then Chief Commercial Officer (March 2017 to March 2018) for Biodesix. Prior to that, Ms. Blosser served as VP of Sales with Integrated Oncology (LabCorp subsidiary). Ms. Blosser began her career in diagnostics at Cytyc Corporation holding several leadership positions in her eight years with the company. Two key roles included: Director of Corporate Advocacy- In this role she effectively advocated and positioned Cytyc’s suite of products to national teaching institutions, the NIH, professional medical societies and government agencies. Product lines included The ThinPrep Pap Test and Imaging System, MammoSite Radiation Therapy System, NovaSure Endometrial Ablation System and FullTerm product line. Wendy also held the role of Regional Business Director. In this position she was responsible for the financial results of the surgical and diagnostic mid-west division. Ms. Blosser holds an M.S. from West Virginia University and a B.S. from Marietta College.

Positions